Condition
Sinus Infection Chronic
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 3 (1)
P 4 (1)
Trial Status
Active Not Recruiting1
Recruiting1
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05454072Not ApplicableActive Not Recruiting
Microbiota Transfer for Chronic Rhinosinusitis
NCT05157685Phase 3Recruiting
Evaluation of the Efficacy of Azithromycin in Idiopathic Purulent Oedematous Sinusitis in Adults
NCT04619160Phase 4UnknownPrimary
Propofol Versus Sevoflurane During FESS
Showing all 3 trials